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Background: Canine parvovirus (CPV) is an important pathogen that causes acute enteric disease in dogs. It has
mutated and spread throughout the world in dog populations. We provide an update on the molecular
characterization of CPV that circulated in Nanjing, a provincial capital in China between 2009 and 2012.
Results: Seventy rectal swab samples were collected from the dogs diagnosed with CPV infection in 8 animal
hospitals of Nanjing. Sequence analysis of VP2 genes of 31 samples revealed that 29 viral strains belonged to
CPV-2a subtype, while other two strains were classified into CPV-2b. To investigate the pathogenicity of the
prevalent virus, we isolated CPV-2a and performed the animal experiment. Nine beagles were inoculated with 105.86
of 50% tissue culture infectious doses (TCID50) of the virus. All the experimentally infected beagles exhibited mild to
moderate mucoid or watery diarrhea on day 4 post-infection (p.i.). On day 9 p.i., characteristic histopathological
lesions were clearly observed in multiple organs of infected dogs, including liver, spleen, kidney, brain and all
segments of the small and large intestines, while viral DNA and antigen staining could be detected in the sampled
tissues. It is notable that canine parvovirus was isolated in one from two brain samples processed.
Conclusion: Our results indicated that CPV-2a is the predominant subtype in Nanjing of China. And this virus
caused extensive lesions in a variety of tissues, including the brain.
Keywords: Canine parvovirus, Genetic analysis, Dog infectionBackground
The canine parvovirus (CPV) infection is a viral illness
that most commonly affects puppies. The infected dogs
develop an acute gastroenteritis characterized by loss of
appetite, vomiting, fever, diarrhea (from mucoid to haem-
orrhagic) and leucopenia [1]. CPV, a member of the
Parvovirus genus, contains a single strand DNA genome
of about 5200 nucleotides that is packaged in an icosahe-
dral capsid [2]. There are three capsid proteins, VP1, VP2
and VP3. VP2 is the major capsid protein, and it plays an
important role in determining viral host ranges and tissue
tropisms [3]. Amino acids substitutions in VP2 gene have
been responsible for genetic and antigenic properties [4].
The virus emerged as dog pathogen in the late 1970's as
host variant of feline panleukopenia virus (FPV) [5,6]. A
few years after its emergence, the original virus type CPV-
2 was replaced by two new antigenic variants, CPV-2a and
CPV-2b [7,8]. Recently, a novel CPV mutant, CPV-2c, is* Correspondence: jfhou@njau.edu.cn
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reproduction in any medium, provided the orwidely distributed and co-existing with other CPV types
in Europe [9,10], North [11,12] and South America
[13,14] countries.
In China, CPV infections were first observed as spor-
adic cases during 1982 (unpublished data). Subsequently,
widespread outbreaks of canine hemorrhagic enteritis
with high morbidity and mortality occurred over the
whole country [15]. Along with the increasing number
of pet dogs in China, CPV infection has emerged as a
veterinary public health concern that affect puppies be-
cause of its high mortality and morbidity [16]. However
there has been too little information concerning the
antigenic types of CPV prevailing in China.
The identification of the subtypes of CPV-2 that are
currently circulating in the canine population is essential
for the understanding of viral evolution and the develop-
ment of measures to control its spread [17]. Antigenic
differences have been demonstrated between CPV vari-
ants in neutralisation tests [18]. There is concern that
the antigenic differences may decrease the effectiveness
of the vaccine based on the original antigenic type, CPV-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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protect dogs against challenge from any of the current
CPV types [19], there are still many cases of clinical
parvovirus in dogs. For example, in 2007, an outbreak of
CPV-2c was reported in Italy in the vaccinated dogs with
CPV-2-based vaccine [20]. Some authors have suggested
an update of the virus strains in current vaccines, taking
into account the existing partial protection [21,22]. Con-
sidering this, it is important for us to isolate new parvo-
virus variants circulating in the field in order that more
effective vaccines are prepared from an immunogenic
point of view.
To provide an update on the molecular characterization
of CPV that circulated in Nanjing, China, in the study, we
characterized canine parvovirus from fecal samples of
domestic dogs by polymerase chain reaction followed by
sequencing, isolated the prevalent virus and performed
in vivo experiments to investigate the pathogenicity of
this virus.
Results
Prevalence and genetic characterization of canine
parvovirus
One DNA band of the expected size (583 bp), correspond-
ing to the partial amplification of the VP2 gene, was
observed by gel electrophoresis in all the 70 samples diag-
nosed with CPV infection. Thirty-one samples were se-
lected for sequence analysis. Then the sequences were
submitted to GenBank. GenBank accession numbers of the
VP2 genes of 31 samples are numbered from KC556927 to
KC556957. Sequence comparisons showed nucleotide
identities of 98.2–100% among the CPV strains in Nanjing,
China. Nucleotide sequences were translated into aa se-
quences to identify the types. Only two (designated CPV-
JS60 and CPV-JS63) out of the 31 samples presented a
GAT codon at the same position of VP2 protein, character-
istic of CPV-2b, while other 29 samples presented an AAT
codon at position 426 of the VP2 protein, characteristic of
CPV-2a. The main differences in some amino acids of the
CPV VP2 gene products are summarized in Table 1. Spe-
cifically, these strains had Asp or His at position 427, Thr
or Ala at position 440, Thr or Asn at position 445, Pro or
His at position 512, and Pro or Thr at position 580.
Virus isolation and experimental infection
Considering that CPV-2a is epidemiologically predomin-
ant in dog populations of Nanjing in China, we isolated
the type CPV-2a from three fecal samples in order to
further investigate its pathogenicity. Out of three sam-
ples, one isolate, CPV-JS2, was obtained. After second
blind passages, typical CPE in the form of rounding,
increased granularity and detached cells appeared in the
infected F81 cells. The observation of electron microscope
showed a large quantity of 20–25 nm virus particles withcubic symmetry, typical of parvovirus (data not shown).
The titre of the isolated virus determined by the method
of Reed and Munch was 104.86 TCID50/100 μl.
For investigating the pathogenicity of the prevalent
virus, we performed the artificial infection experiment of
CPV-JS2 in beagles. Clinical signs in the dogs given the
isolated virus orally were exhibited on day 3 post-infection
(p.i.), when four out of nine dogs developed fever (body
temperature ≥38.9°C), following anorexia, depression, and
mild dehydration. Mild to moderate mucoid or watery
diarrhea were exhibited in all dogs of experimentally
infected group on day 4 p.i. Clinical scores of the experi-
mentally infected beagles peaked on day 7 p.i. (Figure 1).
And the dogs began with vomiting and three had bloody
diarrhea. The infected dogs were given a supportive treat-
ment with oral electrolytes on welfare grounds. But on day
9 p.i., the clinical signs in two dogs progressed to include
severe vomiting, refusal of food and water, and profuse
smelly, bloody diarrhea despite the supportive treatment,
and therefore had to be euthanized. The remaining seven
were treated by intravenous fluids, anti-nausea medica-
tions, and antibiotics to prevent secondary infections. On
day 12 p.i., clinical signs of one dog were relieved, with the
exception of mild diarrhea. The last six dogs showed no
any signs of vomiting or diarrhea. The dogs in the control
group remained healthy and had a normal body tem-
perature (38.5 ± 0.2°C) throughout the experiment.
In the two humanely euthanized dogs, hemorrhagic
enteritis of the small intestine was the predominant
gross lesion observed from the pathology autopsy. There
were no apparent gross lesions in other tissues (data not
shown).
Virus detection in rectal swabs and sera
All rectal swabs that were collected from all dogs at
1 day before infection were CPV negative. On day 4 p.i.,
some CPV-infected dogs (5/9) showed positive results in
rectal swabs. All rectal specimens from CPV-infected dogs
were positive after day 5 p.i. However on day 12 p.i., the
number of positive results in rectal swabs decreased, and
2/7 rectal swab samples showed negative results.
Viral DNA was detected in the sera from six of nine
infected dogs four days after inoculation and in all
infected dogs five days after inoculation. But from day 8
p.i., no viral DNA was detected in any infected dogs.
Further virus isolation demonstrated that CPV could be
recovered from the dogs with positive viral DNA, but
not from those with negative viral DNA (data not
shown).
Real-time PCR for quantitation of viral loads
Real-time PCR assays were carried to measure viral
DNA loads in the main organs of two humanely eutha-
nized dogs. All tested samples were positive and mean
Table 1 The main differences in some amino acids of the VP2 gene of CPV strains analyzed in this study
Strains
Origin Year Accessionno.
Place of amino acid site
Gene type
426 427 436 440 445 450 474 476 512 515 577 580
Reference strains
CPV-15 U.S. 1984 M24003 N D I T T T F T P S Q P CPV-2a
CPV-V120 Vietnam 2000 AB054215 N D I T T T F T P S Q P CPV-2a
CPV-39 U.S. 1984 M74849 D D I T T T F T P S Q P CPV-2b
CPV-Taichung Taiwan 2004 AY869724 D D I T T T F T P S Q P CPV-2b
CPV-G7/97 Germany 1997 FJ005196 E D I T T T F T P S Q P CPV-2c
Chinese strains
CPV-JS1 Nanjing 2009 KC556927 N H - - N - - - - - - - CPV-2a
CPV-JS2 Nanjing 2009 KC556928 N H F A N - - - - - - - CPV-2a
CPV-JS3 Nanjing 2009 KC556929 N H - A N - - - - - - - CPV-2a
CPV-JS4 Nanjing 2009 KC556930 N H - - - - - - - - - - CPV-2a
CPV-JS11 Nanjing 2010 KC556931 N - - - N - - - - - - - CPV-2a
CPV-JS12 Nanjing 2010 KC556932 N - - A - - - - - - - - CPV-2a
CPV-JS13 Nanjing 2010 KC556933 N - - A - - - - - - - T CPV-2a
CPV-JS14 Nanjing 2010 KC556934 N - - - - - - - - - - T CPV-2a
CPV-JS15 Nanjing 2010 KC556935 N - - - - - - - - - - T CPV-2a
CPV-JS16 Nanjing 2010 KC556936 N - - A - - - - - - - - CPV-2a
CPV-JS17 Nanjing 2010 KC556937 N - - A - - - - - - - - CPV-2a
CPV-JS18 Nanjing 2010 KC556938 N - - - N - - - H - - - CPV-2a
CPV-JS38 Nanjing 2011 KC556939 N - - A - - - - - - - - CPV-2a
CPV-JS39 Nanjing 2011 KC556940 N - - A - - - - - - - - CPV-2a
CPV-JS40 Nanjing 2011 KC556941 N - - A N - - - - F H T CPV-2a
CPV-JS41 Nanjing 2011 KC556942 N H - - N N - - H - - T CPV-2a
CPV-JS42 Nanjing 2011 KC556943 N H - A N - - - H - - - CPV-2a
CPV-JS43 Nanjing 2011 KC556944 N - - - - - S - - - - T CPV-2a
CPV-JS44 Nanjing 2011 KC556945 N - - - - - - - - - - - CPV-2a
CPV-JS45 Nanjing 2011 KC556946 N H - A N N - - H F - - CPV-2a
CPV-JS46 Nanjing 2011 KC556947 N - - - N - - I - - - - CPV-2a
CPV-JS47 Nanjing 2011 KC556948 N - - - - - - - - - - - CPV-2a
CPV-JS58 Nanjing 2012 KC556949 N - - - - - - - - - - - CPV-2a
CPV-JS59 Nanjing 2012 KC556950 N - - A - - - - - - - - CPV-2a
CPV-JS60 Nanjing 2012 KC556956 D - - - - - - - - - - - CPV-2b
CPV-JS61 Nanjing 2012 KC556951 N - - - - - - - - - - - CPV-2a
CPV-JS62 Nanjing 2012 KC556952 N - - A - - - - - - - - CPV-2a
CPV-JS63 Nanjing 2012 KC556957 D - - A - - - - - - - - CPV-2b
CPV-JS64 Nanjing 2012 KC556953 N - - A - - - - - - - - CPV-2a
CPV-JS65 Nanjing 2012 KC556954 N - - - - - - - - - - - CPV-2a
CPV-JS66 Nanjing 2012 KC556955 N - - A - - - - - - - - CPV-2a
Identical amino acids are represented by -.
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heart (<104). Interestingly, the virus load was high in the
brain (>107copies/g). There were some differences in
viral DNA loads of affected tissues between the twodogs. Rectum was the tissue with highest viral DNA
load (1.02 × 109 copies/g) in beagle No.4, but duodenum
was the highest tissue (2.22 × 108 copies/g) in beagle
No.6 (Figure 2).
Figure 1 Clinical scores of dogs infected experimentally with
CPV-JS2. The data are expressed as the mean ± standard error.
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In one from two brain samples processed was possible
to isolate canine parvovirus in F81 cells. The presence of
the virus in the cell cultures was confirmed by cyto-
pathic effect (CPE), viral hemagglutination (HA) and
PCR. Typical CPE of parvovirus, such as rounding and
detachment, appeared in the cells after second passage.
The highest HA titer of the virus was 1: 64 with porcine
erythrocytes. A single DNA band of the expected size
(583 bp), corresponding to the partial amplification of
the VP2 gene, was observed by gel electrophoresis.Figure 2 Virus loads in the main organs of two humanely euthanized
virus load in an organ sample from one beagle. Viral loads are expressed a
beagle No.6.Histopathology and immunohistochemistry
On day 9 p.i., tissue samples from two humanely
euthanized beagles were collected for histopathological
examinations and immunohistochemistry (IHC) stain.
The two dogs showed the similar histopathologic lesions
and viral antigen staining in every specific tissue. There
were typical histopathologic lesions in all tested tissues,
except the heart and the lung. Extensive degenerated he-
patocytes were swollen and rounded with vacuoles of
varying sizes in the cytoplasm. Hepatic sinusoid was
hyperemia with erythrocytes (Figure 3A). The number of
lymphocytes in periarterial lymphatic sheath was signifi-
cantly increased and this area was thickened (Figure 3B).
Besides, the hyperemia in artery of spleen trabecula may
be a suggestion for inflammation. In kidney, glomerulus
was swollen and filled up Bowman’s capsule. Endothelium
and mesenchymal cell in glomerulus showed proliferation.
Epithelia of renal tubules underwent degeneration and
necrosis (Figure 3C). Glial cells hyperplasia came with
neuronophagia (a degenerative or dead neuron was
engulfed by microgliocytes) (Figure 3D). Similar patho-
logical lesions were observed in all segments of the
small and large intestines. Disruption of the villous
architecture was characterized by blunting and fusing
of villi. Epithelia of mucosa underwent degeneration,
necrosis and desquamation. These changes appeared
to be more significant in the duodenum (Figure 3E)
and the jejunum (Figure 3F).
In the IHC staining, viral antigens were detected in the
lesions of various organs. They were primarily found in
degenerated hepatocytes (Figure 4A), the marginal zone ofbeagles infected experimentally CPV-JS2. Every column represents
s log10 DNA copy numbers per gram of sample. beagle No.4;
Figure 3 Histopathologic appearances of H&E-stained liver, spleen, kidney, brain, duodenum and jejunum of two humanely
euthanized beagles infected experimentally CPV-JS2. A: liver, showing extensive degenerated hepatocytes, hyperemia of hepatic sinusoid;
100×. B: spleen, showing the significantly thickened periarterial lymphatic sheath (t), and the hyperemia in artery of spleen trabecular (h); 100×.
C: kidney, showing endothelium and mesenchymal cell proliferation in glomerulus, and renal tubules epithelia degeneration and necrosis; 400×.
D: brain, showing neuronophagia (arrow); 400×. E: duodenum, showing necrosis of mucous membrane (arrow) and cell proliferation in lamina
propria; 100×. F: jejunum, showing necrotic epithelia; 100×.
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kidney (Figure 4C), necrotic nerve cells in the cere-
brum (Figure 4D), and necrotic epithelia of the duode-
num (Figure 4E) and the jejunum (Figure 4F). CPV
antigens were seen also in myocardial fibers of the
heart (Figure 4G) and in bronchiolar epithelial cellsFigure 4 Immunohistochemistry (IHC) detection of CPV antigen in co
experimentally CPV-JS2. A: liver, virus antigens in degenerated hepatocyt
kidney, virus antigens in necrotic renal epithelial cells; 400×. D: brain, virus
columnar epithelium of intestinal gland; 400×. F: jejunum, virus antigens in
400×. H: lung, virus antigens in bronchioles epithelium, 400×.and walls of atria of the lung (Figure 4H) although no
apparent histologic lesions in these organs.
Discussion
Point mutations in the VP2 protein have been associated
with the CPV types. Sequence analysis can give amplellected tissues of two humanely euthanized beagles infected
es; 400×. B: spleen, virus antigens in marginal zone cells; 400×. C:
antigens in necrotic nerve cells; 400×. E: duodenum, virus antigens in
necrotic epithelium; 400×. G: heart, virus antigens in myocardial fibers;
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by conventional PCR encodes for at least one inform-
ative aa (residue 426) of the VP2 protein [23]. The
change of the amino acid at position 426 can differenti-
ate the CPV2a (Asn), CPV2b (Asp) and CPV2c (Glu)
[24]. CPV has a worldwide distribution. In many coun-
tries in Europe, such as United Kingdom, Germany and
Italy, CPV-2a has been overtaken by CPV-2b or CPV-2c.
Type 2b and 2c isolates predominate in North America
[11,12], whereas CPV-2c is more widespread in South
America [13,14]. India has reported the prevalence of
CPV-2a and CPV-2c [25]. This study, together with pre-
vious findings [15,26], indicated that CPV-2c has not
been detected in China. The sequencing results of 31
CPV samples indicated that the CPV-2a variant is more
popular than the CPV-2b variant in Nanjing, China. A
similar epidemiological pattern has been reported in
Brazil, where all circulating strains were characterized as
CPV-2a [27]. Also, some reports showed that CPV-2a is
the predominant variant in Asia [25,28,29] and Australia
[30]. On the contrary, Zhang et al. [15] showed the high
frequency of CPV-2b (21 out of 23) in China. But an-
other research group [26] reported that three types of
CPV, including CPV-2, CPV-2a, and CPV-2b, could be
detected, and CPV-2a was predominant in China. These
differences might be due to sample localities and pe-
riods. The former study focused on Jiangsu, Anhui and
Zhejiang strains from 2006 to 2009 [15], while later sam-
ples were collected from Sichuan, Yunnan, Guizhou and
Jilin Provinces from 1983 to 2008 [26]. Interestingly,
only two strains of CPV-2a reported by Zhang et al. [15]
were collected from Nanjing, further supporting the
present study that CPV-2a is the prevalent subtype in
Nanjing, China.
The deduced amino acid sequences from 31 VP2 gene
products in this work revealed the variability at residues
427, 440, 445, 512 and 580. Interestingly, the greatest
variability in the VP2 protein occurred (within the GH
loop) at position 440. This finding is in accordance with
the finding of Kang et al. [28]. It has been reported that
a high level of substitution in this region has been asso-
ciated with the evolution of antigenic variants in circu-
lating parvovirus types [31-33].
In the present experiment, inoculation of CPV-2a in-
duced significant clinical symptoms in all infected ani-
mals, and two of them had to be euthanized. It is not
clear whether one CPV-2 variant has a greater infection
or virulence over the others. The previous work showed
that experimental infection of beagles with the original
type 2 infrequently resulted in severe clinical disease like
that seen in natural disease [34]. Meunier et al. [35]
reported that the original type 2 caused clinical signs in
about 30% of infected beagles. In comparison to the ori-
ginal type 2, the antigenic variants 2a and 2b have beenreported to cause a more severe disease [36]. Moon et al.
[37] found that the overall pathogenicity of the CPV-2a
variants (CPV-2a-I and 2a-V) was severer compared to the
CPV-2b variant. From the above works, pathogenetic po-
tential of CPV seems to be relative to the types of variants.
But recently, there are a few published studies that de-
scribed CPV-2c infections. Decaro et al. [38] reported that
all pups infected with CPV-2c displayed clinical signs of
parvovirosis, but none showed either hemorrhagic diarrhea
or vomiting and all recovered in a few days. The findings
from Spibey et al. [19] showed that all six of the infected
dogs with CPV-2c became severely ill, and three of them
had to be euthanized. Therefore it is reasonable to think
that the types of CPV variants may not determine their
pathogeneticity. This speculation is supported by the inves-
tigation from Decaro et al. [39] that similar patterns of tis-
sue distribution were observed in all the examined dogs
irrespective of the antigenic variant causing the disease.
Parvovirus replication in dogs was mainly seen in
highly mitotically active tissues, such as lymphoid tissue,
bone marrow, or the epithelium of the gastrointestinal
tract [40]. Despite the existence of several studies on the
antigenic characterization and geographic distribution of
type 2a and 2b CPVs in China, few data are available on
the pathobiology of the CPV-2 variants. Our study showed
that, the CPV-2a variant comprises 93.5% (29/31) of the
field strains in Nanjing, China. All the experimentally
infected beagles with CPV-2a resulted in clinical disease
similar to that of natural disease (mucoid or bloody diar-
rhea, vomiting and etc.). Especially on day 9 p.i., two of
nine had to be euthanized due to the poor prognosis even
after treatment, suggesting that the Chinese CPV-2a iso-
late was life-threatening. Also, virus shedding from feces
could be detected from day 4 p.i., and this could represent
a source of viruses which could potentially infect other
susceptible dogs.
CPV DNA was demonstrated in all the sampled
tissues, showing a wide distribution of the virus in the
infectious dogs. To demonstrate the presence of viral
DNA is associated to effective replication and expression
of viral proteins in the sampled organs, we identified
CPV antigens using immunohistochemistry. All tested
samples showed positive antigen staining. It suggests
that the disease may lead to a generalized infection
and cause viral replication and attack in other tissues
other than the gastrointestinal tissues. The systematic
infection was probably due to viral spread in the or-
ganism through the blood. This assumption can be
supported by this finding that viremia was detected
from day 4 p.i.
Among the tested samples, the viral DNA loads of the
heart were lowest. And histological examination showed
no significant lesions in this organ. Although CPV is
known to be also able to replicate in cardiac cells and
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where vaccination of breeding dogs is common [41].
Interestingly, this virus appears to be capable of replicat-
ing in cerebral neurons in dogs. To further demonstrate
this, we performed the virus isolation from brain
samples and obtained positive result. To our know-
ledge, the parvovirus isolation from canine brain has
never been reported. Schaudien et al. [42] also found
that parvovirus antigen, as well as parvovirus DNA
and mRNA, was detected within the brains of five
Cretan Hound puppies suffering from a puppy shaker
syndrome, further supporting the possibility of infec-
tion of the canine brain during systemic parvovirus
infections. However, the findings are different from a
precious report, wherein parvovirus antigen was not
detectable in 40 canine brains of dogs with parvo-
virus enteritis [43]. The significantly different results
might be due to viral strains, the host’s immunity, or
the time point of infection.
The results pointed here may help to achieve a better
understanding of the current status of CPV-2 infection
in dogs from Nanjing, China. However, as to virulence
of CPV-2a, since only one strain was examined, we can
not determine whether CPV-2a circulating in Nanjing is
more lethal or different in its tropism than others. More
works will need to be done in the future study.
Conclusions
The present study demonstrated that 2a is the main
CPV type that circulated in Nanjing, China between the
years 2009 and 2012, and the prevalent virus has been
shown to be able to spread to all sampled tissues in
dogs, including the brain. Further epidemiological
surveillance and pathogenetic investigation of the new
antigenic strains of CPV are needed for controlling
parvovirus diseases in dogs.
Methods
Sampling and sample preparation
Rectal swab specimens (n = 70) were collected from the
dogs diagnosed with CPV infection, 1 to 15 months, in 8
major animals hospitals located in Nanjing, the capital
city of Jiangsu province in China, from years 2009 to
2012. Only the animal hospitals with the capability of
performing the diagnostic studies were involved in this
study. The diagnostic criteria for CPV infection were
based on clinical signs, the examination of blood and
antibody titration or antigen detection. Final diagnosis
considered compatible with CPV enteritis included
hemorrhagic gastroenteritis, gastroenteritis or acute on-
set of vomiting or diarrhea. The positive laboratory test
results for CPV included leukopenia (a WBC of <5000
cells/μl) or a single CPV hemagglutination inhibition
(HI) antibody titer ≥ 1: 5120 [44]. The samples weretested positive to CPV-2 by a CPV commercial diagnos-
tic kit (Rapitest, South Korea).
The collected samples were emulsified in 1 ml sterile
phosphate-buffered saline (PBS) and centrifuged at
10000 rpm for 10 min at 4. The supernatant was col-
lected for PCR amplification.
DNA extraction and PCR amplification
Hundred microlitres of the supernatant was used for
template DNA preparation with a Qiagen viral DNA kit.
About 0.1 to 1 μg of DNA was added per reaction. PCR
amplification was carried out under standard conditions
using VP2-F (5′-CAGGAAGATATCCAGAAGGA-3′)
and VP2-R (5′-GGTGCTAGTTGATATGTAATAAAC
A-3′) [23]. Amplicons (583 bp) were visualized by GelSafe
nucleic acid dye (10000 × solution; YuanPingHao-bio,
Beijing, China) added to 2% agarose gels after electrophor-
esis was complete. Sterile water was used instead of the
specimen as the negative control in every test. PCR
products were purified with the Agarose Gel DNA Puri-
fication Kit (TaKaRa) and cloned into the pMD18-T
vector (TaKaRa). Positive clones were selected and
sequenced.
Virus isolation
Fecal samples from three dogs which were positive by
PCR were used for virus isolation. The procedure was
carried out as described by Hirayama et al. [45]. Briefly,
the sample was homogenized (10%, w/v) in PBS (pH 7.2)
and subsequently clarified at 12000 rpm for 10 minutes.
The clear supernatants were filtered using 0.22 μm
membrane filter (Millipore). Then filtrates were treated
with penicillin and streptomycin at 4 overnight and in-
oculated into F81 cells. The infected monolayers with
CPE were harvested at 4 days post-infection by three cy-
cles of alternative freezing and thawing. The virus super-
natants were screened for the presence of virus by PCR
using the same primer pair VP2-F/VP2-R. The CPV sus-
pensions were titrated using 50% tissue culture infective
dose (TCID50) assay [46]. Also, the samples were col-
lected for morphological examination of viral particles
by negative staining and electron microscope (Hitachi
H-7650) [47].
Sequence analysis
In order to ensure that one sample was selected for se-
quence analysis at each clinic each year, we used a
sample proportion of 40% from 2010 to 2012. All the
four samples from Animal Clinics of Nanjing Agricultural
University in 2009 were selected because of limited data.
Therefore, a total of 31 samples were sequenced. The
sequences from this study were compared with the
VP2 sequences of 5 reference strains of CPV (CPV-15,
CPV-V120, CPV-39, CPV-Taichung and CPV-G7/97).
Zhao et al. Virology Journal 2013, 10:272 Page 8 of 10
http://www.virologyj.com/content/10/1/272Reference sequences were obtained from the National
Center for Biotechnology Information (NCBI; http://www.
ncbi.nlm.nih.gov). Comparisons of nucleotide and deduced
amino acid sequences were made using DNASTAR
software.Experimental infection
Twelve healthy beagles aged 7–8 weeks old were obtained
from unvaccinated unexposed bitches in Nanjing Medical
University Experimental Animal Center, and therefore
devoid of maternally derived antibodies against canine
parvovirus. They were housed in a BSL-2 isolation
facility under standard husbandry conditions. The dogs
were kept 1 week for acclimation before experiment.
Food and water were provided ad libitum. All the ex-
periments were performed in a BSL-2 isolation facility.
Dogs were confirmed to be negative for CPV using HI
assays as described by Jeoung et al. [48]. All animal
experiments complied with the guidelines of Animal
Welfare Council of China. The protocol was approved by
the Animal Ethics Committee of Nanjing Agricultural
University. All efforts were made to minimize suffering.
Dogs used in this study were housed and cared for in
accordance with the Guide for the Care and Use of
Laboratory Animals (eighth edition). During the experi-
ment, the animal’s condition was assessed by a respon-
sible veterinarian.
Nine beagles were randomly chosen and assigned into
the experimentally infected group. A 1 ml aliquot of
virus stock (105.86 TCID50/ml) was used to inoculate
each of nine beagles oronasally. The other three beagles
were inoculated with 1 ml sterile PBS each as control.
To avoid contact transmission, each dog is raised alone
in the cage.Clinical observations
Clinical observations (e.g. body weight, body temperature,
and the presence of diarrhea) of each animal were moni-
tored for 12 days post infection (p.i.) or until death using a
record sheet. Some clinical signs were assigned scores to
evaluate the severity of the disease as described by Moon
et al. [37], with some modifications, and given in Table 2.
The average clinical scores were calculated based on the
daily score. The number of white blood cell (WBC) wasTable 2 Assessment of clinical scores
Body temperature (°C) WBC count (×103 μl-1) Diarrhea
0 = 37.7-39.4 1 = 5.9-4.0 1 = Mucoi
1 = 39.5-39.9 2 = 3.9-2.0 2 = Fluid
2 = 40–40.4 3 = <2.0 3 = Blood
3 =≥40.5determined using an automated blood cell counter (ABX
MicRos 60, France).Sample collection
Rectal swabs were collected individually to detect virus
shedding from days 1 to 12 p.i. The swab was removed
from anus and the tip of the swab was immersed care-
fully in an Eppendorf tube that contained 1 ml of virus
transport medium (phosphate-buffered saline containing
10000 U/ml penicillin, 10000 μg/ml streptomycin and
250 μg/ml gentamycin). Also, serum samples from days
1 to 12 p.i. were collected for detection of CPV. Two
beagles which were humanely euthanized on days 9 p.i.
were necropsied and sampled. Heart, liver, spleen, lung,
kidney, brain, duodenum, jejunum, ileum, cecum, colon
and rectum were collected for virus detection and histo-
pathological examinations.Virus detection and quantitative PCR
PCR amplification for the conserved region of VP2 gene
was carried out to detect serum and fecal samples using
the same primer pair VP2-F/VP2-R. Quantitative assays
were carried to measure viral DNA loads in the main or-
gans as described by Decaro et al. [49]. Real-time PCR
was run in an ABI 7300 Real Time PCR SystemHistopathologic examination and immunohistochemistry
Tissue samples from two humanely euthanized beagles
were fixed by submersion in Bouin’s solution and em-
bedded in paraffin wax. Serial 4-μm sections were pre-
pared for hematoxylin and eosin (H&E) staining and
IHC. For the IHC assay, tissue sections were prepared
on slides and stained using an immunoperoxidase test.
Briefly, a 1:1000 dilution of rabbit-derived polyclonal
antibody (produced in our laboratory using the purified
CPV described in this study) was applied as the primary
antibody, followed by the application of biotinylated goat
anti-rabbit IgG as secondary antibody (DingGuo, Beijing,
China), which was then detected by horseradish peroxid-
ase (HRP)-conjugated streptavidin (DingGuo, Beijing,
China). An enhanced HRP-DAB chromogenic substrate
kit (TianGen, Beijing, China) was used for chromogenic
detection following the manufacturer’s instructions, and
then slides were counterstained with hematoxylin.Loss of appetite Vomiting Depression
d 0 = Absent 1 = Mild 0 = Absent
1 = Present 2 = Moderate 1 = Present
y 3 = Severe
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